Primary ameloblastoma of the sinonasal tract: a clinicopathologic study of 24 cases
- PMID: 9477098
- DOI: 10.1002/(sici)1097-0142(19980215)82:4<667::aid-cncr8>3.0.co;2-i
Primary ameloblastoma of the sinonasal tract: a clinicopathologic study of 24 cases
Abstract
Background: Ameloblastomas are locally aggressive jaw tumors with a high propensity for recurrence and are believed to arise from the remnants of odontogenic epithelium. Extragnathic ameloblastomas are unusual and primary sinonasal tract origin is extraordinarily uncommon.
Methods: Twenty-four cases of ameloblastoma confined to the sinonasal tract were retrieved from the Otorhinolaryngic-Head & Neck Pathology and Oral-Maxillofacial Pathology Tumor Registries of the Armed Forces Institute of Pathology between 1956 and 1996.
Results: The patients included 5 females and 19 males with an age range of 43-81 years, with a mean age at presentation of 59.7 years. The patients presented with an enlarging mass in the maxillary sinus or nasal cavity (n = 24), sinusitis (n = 9), or epistaxis (n = 8). Unilateral opacification of the maxillary sinus (n = 12) was the most common radiographic finding. Histologically, the tumors exhibited the characteristic features of ameloblastoma, including peripherally palisaded columnar cells with reverse polarity. The majority of the tumors showed a plexiform growth pattern. Fifteen tumors demonstrated surface epithelial derivation. Surgical excision is the treatment of choice, ranging from conservative surgery (polypectomy) to more aggressive surgery (radical maxillectomy). Five patients experienced at least 1 recurrence, usually within 1 year of initial surgery. With follow-up intervals of up to 44 years (mean, 9.5 years), all 24 patients were alive without evidence of disease or had died of unrelated causes, without evidence of disease.
Conclusions: Primary ameloblastoma of the sinonasal tract is rare. In contrast to their gnathic counterparts, sinonasal tract tumors have a predilection for older age men. Therapy should be directed toward complete surgical resection to prevent local tumor recurrence.
Similar articles
-
Ameloblastoma of the sinonasal tract: A case report.Ear Nose Throat J. 2010 Feb;89(2):70-1. Ear Nose Throat J. 2010. PMID: 20155674
-
Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature.Am J Surg Pathol. 2000 May;24(5):640-50. doi: 10.1097/00000478-200005000-00002. Am J Surg Pathol. 2000. PMID: 10800982 Review.
-
An unusual clinical and histopathologic presentation of a maxillofacial ameloblastoma: a literature review and case report.Gen Dent. 2024 Nov-Dec;72(6):54-61. Gen Dent. 2024. PMID: 39451090 Review.
-
[Maxillary ameloblastoma extending into the sinonasal tract].Pathologe. 2013 Jul;34(4):335-7. doi: 10.1007/s00292-013-1753-6. Pathologe. 2013. PMID: 23436120 German.
-
Primary sinonasal ameloblastoma.APMIS. 2005 Feb;113(2):148-50. doi: 10.1111/j.1600-0463.2005.apm1130210.x. APMIS. 2005. PMID: 15723691
Cited by
-
Ameloblastoma: a clinical review and trends in management.Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1649-61. doi: 10.1007/s00405-015-3631-8. Epub 2015 Apr 30. Eur Arch Otorhinolaryngol. 2016. PMID: 25926124 Review.
-
Infrasellar craniopharyngiomas: case report and review of the literature.Skull Base. 2001 May;11(2):121-8. doi: 10.1055/s-2001-14432. Skull Base. 2001. PMID: 17167611 Free PMC article.
-
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.Head Neck Pathol. 2022 Mar;16(1):1-18. doi: 10.1007/s12105-021-01406-5. Epub 2022 Mar 21. Head Neck Pathol. 2022. PMID: 35312976 Free PMC article. Review.
-
Acanthomatous ameloblastoma- a case report.J Int Oral Health. 2013 Apr;5(2):54-8. J Int Oral Health. 2013. PMID: 24155592 Free PMC article.
-
Clinicopathologic Profile, Management and Outcome of Sinonasal Ameloblastoma-A Systematic Review.J Clin Med. 2023 Jan 3;12(1):381. doi: 10.3390/jcm12010381. J Clin Med. 2023. PMID: 36615180 Free PMC article. Review.